Thoracic Vascular Stent Grafts Market Analysis

The global thoracic vascular stent grafts market is segmented and analyzed for demand and supply by end-user into hospitals, ambulatory surgical centers, medical centers, and others. Out of these types of segments, the hospitals segment is estimated to radically grow over the projected time frame. The growth of the segment can be attributed to the mounting incidences of CVDs throughout the world, coupled with a global increase in healthcare expenditure. For instance, as per the World Bank, global healthcare expenditure expanded to 9.83% in 2019 from 9.7% in 2018. Furthermore, the mounting number of patients visiting hospitals for diagnosis, followed by the availability of better medical reimbursement are some significant factors that are estimated to push the market growth further throughout the projected time frame.

The global thoracic vascular stent grafts market is also segmented and analyzed for demand and supply by product type into endovascular stent graft, hemodialysis access graft, peripheral vascular, and others. Amongst these segments, the endovascular stent graft segment is anticipated to grasp the largest market share, backed by the escalating adoption of the endovascular stent graft in the treatment of aneurysms including thoracic aortic aneurysms. Besides this, these stent grafts, in conjunction with antibiotics, can be utilized to treat mycotic aneurysms. In addition to this, escalating technology improvements in endovascular stent grafts have led to the development of a novel approach for treating a variety of aortic aneurysms, including those in the visceral arteries, this is another major factor that is estimated to significantly boost the growth of the market throughout the forecast period.

Our in-depth analysis of the global thoracic vascular stent grafts market includes the following segments: